Kent Edward Kester - Oct 8, 2025 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Role: Director
Signature: /s/ Zuraiz Chaudhary, attorney-in-fact for Kent Edward Kester
Stock symbol: TTRX
Transactions as of: Oct 8, 2025
Transactions value $: $0
Form type: 4
Date filed: 10/10/2025, 09:42 AM
Previous filing: Oct 7, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kester Kent Edward	Director	C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE	/s/ Zuraiz Chaudhary, attorney-in-fact for Kent Edward Kester	2025-10-10	0002087469

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TTRX	Common Stock	Award	$0	+10K		$0.00	10K	Oct 8, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects an award of restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs will vest upon the earlier of the first anniversary of the grant date or a change in control of the Issuer, in each case, subject to the reporting person's continuous service through the vesting date.

Content

Reflects an award of restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs will vest upon the earlier of the first anniversary of the grant date or a change in control of the Issuer, in each case, subject to the reporting person's continuous service through the vesting date.